HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Haines, S. J. Articles by Chittum, C. J. Search for Related Content PubMed Articles by Haines, S. J. Articles by Chittum, C. J.

Which Operation for Trigeminal Neuralgia

Department of Neurological Surgery, Medical University of South Carolina, PO Box 250616, 96 Jonathan Lucas Street, Suite 428, Charleston, SC, 29425, USA; Email: hainesj{at}musc.edu

EXTRACT

INTRODUCTION

Trigeminal neuralgia is a severe, debilitating facial pain disorder that has driven some to suicide when unable to obtain relief. Afflicted patients often describe the pain as ‘shocking’, ‘lightning’, or ‘electric’. If a patient describes pain in the face with words such as these, the diagnosis of trigeminal neuralgia should be at the top of the differential diagnosis.

Historically, treatment has ranged from poultices and salves to injecting boiling water into the cheek to kill the nerve. The introduction of carbamazepine brought successful medical management to many, but adverse effects, and gradual development of refractory pain, mean that some patients still require invasive procedures to achieve pain control. The goal is to identify the point at which surgical intervention should be considered, and then to guide the choice of procedure.

MEDICAL MANAGEMENT

First line therapy for trigeminal neuralgia is carbamazepine (Tegretol). If the patient cannot tolerate carbamazepine, other anticonvulsants ...

[PDF of this article]